Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.
Info & Links
CEO
Brent T. Lucas
Headquarters
4875 WHITE BEAR PARKWAY WHITE BEAR LAKE, MN 55110, UNITED STATES
Envoy Medical, Inc. Class A Common Stock Statistics
Valuation Measures
Market Capitalization2
29.09M
Enterprise Value
39.03M
Enterprise Value/EBITDA(ttm)
-1.83
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
110.98
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
-207.60%
Operating Margin(ttm)
-7607.55%
Profit Margin(ttm)
-9141.51%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
744.37%
Return on Assets(ttm)
-262.28%
Income Statement
Revenue(ttm)
278.00K
Revenue Per Share(ttm)
0.01
Gross Profit(ttm)
-570.00K
EBITDA(ttm)3
-21.29M
Net Income Available to Common(ttm)
-23.69M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
2.36
52-Week Change
-77.86%
S&P 500 52-Week Change
-5.08%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
20.36M
Dividend Yield
0.00%
Float4
8.00M
% Held by Insiders
60.50%
% Held by Institutions
8.59%
Balance Sheet
Total Cash(mrq)
4.42M
Total Cash Per Share(mrq)
0.22
Total Debt(mrq)
14.36M
Total Debt/Equity(mrq)
-77.48%
Current Ratio(mrq)
0.79%
Quick Ratio(mrq)
0.61%
Book Value Per Share(mrq)
-0.94
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.69
Free Cash Flow(ytd)
-15.07M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.